Jeremy Friedman Net Worth

The estimated Net Worth of Jeremy Friedman is at least $4.28 Milione dollars as of 16 August 2018. Jeremy Friedman owns over 15,151 units of Integer Corp stock worth over $2,149,401 and over the last 8 years Jeremy sold ITGR stock worth over $2,131,437.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jeremy Friedman ITGR stock SEC Form 4 insiders trading

Jeremy has made over 8 trades of the Integer Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Jeremy exercised 15,151 units of ITGR stock worth $296,051 on 16 August 2018.

The largest trade Jeremy's ever made was exercising 23,688 units of Integer Corp stock on 29 December 2017 worth over $2,943,234. On average, Jeremy trades about 7,059 units every 18 days since 2016. As of 16 August 2018 Jeremy still owns at least 17,299 units of Integer Corp stock.

You can see the complete history of Jeremy Friedman stock trades at the bottom of the page.

Insiders trading at Integer Corp

Over the last 8 years, insiders at Integer Corp have traded over $11,995,808 worth of Integer Corp stock and bought 28,350 units worth $1,274,625 . The most active insiders traders include Thomas J Hook, Filippo Passerini e Martin C Maxwell. On average, Integer Corp executives and independent directors trade stock every 14 days with the average trade being worth of $717,544. The most recent stock trade was executed by Diron Smith on 1 September 2024, trading 168 units of ITGR stock currently worth $20,874.

What does Integer Corp do?

integer holdings corporation (nyse:itgr) is a leader in advanced medical device outsourcing (mdo) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. additionally, through electrochem, an integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. the company's medical device manufacturing brands include greatbatch™ medical and lake region medical™. additional information is available at www.integer.net.

Complete history of Jeremy Friedman stock trades at Integer Corp

Integer Corp executives and stock owners

Integer Corp executives and other stock owners filed with the SEC include:

• Joseph Dziedzic,
  President, Chief Executive Officer, Director
• Joseph W. Dziedzic,
  Pres, CEO & Director
• Jason Garland,
  Chief Financial Officer, Executive Vice President
• Kirk Thor,
  Chief Human Resource Officer, Executive Vice President
• Payman Khales,
  President - Cardio and Vascular
• Jennifer Bolt,
  Senior Vice President - Global Operations
• Joseph Flanagan,
  Executive Vice President - Quality and Regulatory Affairs
• Jason K. Garland,
  Exec. VP & CFO
• Payman Khales,
  Pres of Cardio & Vascular
• Jennifer M. Bolt,
  Sr. VP of Global Operations & ESG
• Joel D. Becker,
  Pres of Cardiac Rhythm Management & Neuromodulation
• Bill Sanford,
  Independent Chairman of the Board
• Jean Hobby,
  Independent Director
• Martin Maxwell,
  Independent Director
• Pamela Bailey,
  Independent Director
• James Hinrichs,
  Independent Director
• William Summers,
  Independent Director
• Donald Spence,
  Independent Director
• Filippo Passerini,
  Independent Director
• Anthony Borowicz,
  Senior Vice President, Strategy, Corporate Development
• Joel Becker,
  President, CRM & Neuromodulation
• Margaret Carthy,
  Sr. VP of Quality and Regulatory Affairs
• Kirk K. Thor,
  Exec. VP & Chief HR Officer
• McAlister C. Marshall II,
  Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec.
• Elizabeth K. Giddens,
  Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec.
• Carter Houghton,
  Pres of Portable Medical & Electrochem
• Margaret Carthy,
  EVP, Qlty & Regulatory Affairs
• Jeremy Friedman,
  EVP, COO
• Gary J Haire,
  EVP & Chief Financial Officer
• Thomas J Hook,
  President & CEO
• Declan Smyth,
  Pres., Advanced Surgical, Orth
• Jose Antonio Gonzalez,
  President, CRM & Neuro
• Peter H Soderberg,
  Director
• Kristin Trecker,
  Chief Human Resource Officer
• Timothy G Mc Evoy,
  Sr. VP, Gen. Counsel & Sec.
• Thomas J Mazza,
  VP, Corporate Controller
• John A Harris,
  EVP, Global Ops and Manufactur
• Michael L Spencer,
  Chief Ethics & Compliance Of
• Tommy P Thomas,
  VP, Corporate Controller
• Diron Smith,
  EVP, Chief Financial Officer
• Carter Houghton,
  President, Electrochem
• Elizabeth Giddens,
  SVP, General Counsel
• Jim Stephens,
  President, CRM & Neuro
• Alvin Tyrone Jeffers,
  Director
• Sheila Antrum,
  Director
• Cheryl C Capps,
  Director
• Mc Alister C Ii Marshall,
  SVP, Gen Counsel & Secretary
• Andrew Senn,
  SVP, Strategy and Business Dev